Advanced Cell Technology Announces Webcast of Corporate Presentation at Annual Shareholders’ Meeting Today

  Advanced Cell Technology Announces Webcast of Corporate Presentation at
  Annual Shareholders’ Meeting Today

   Webcast to Commence at 9:15 a.m. PDT After Formal Portion of Meeting has
                                  Concluded

Business Wire

MARLBOROUGH, Mass. -- April 26, 2012

Advanced Cell Technology, Inc. (“ACT”;OTCBB: ACTC), a leader in the field of
regenerative medicine, announced that it will webcast today’s corporate
presentation at 9:15 a.m. PDT, after the formal portion of its Annual
Shareholders’ Meeting has concluded. Prior to the webcast, proxy voting will
be completed and the results announced to the shareholders in attendance. The
meeting is open to shareholders of record as of March 1, 2012. After the
corporate presentation, the Company will address questions from shareholders
in attendance, as well as electronically via the webcast.

The webcast will be available live and via replay at:
http://us.meeting-stream.com/advancedcelltechnology042612

The Presentation schedule is as follows:

  *Corporate Overview- Gary Rabin, Chairman and CEO
  *Pre-clinical Programs Summary- Robert Lanza, M.D., CSO
  *RPE Clinical Program Update and FDA planning for Phase 2- Ed Mickunas, VP
    of Regulatory and Clinical Affairs
  *Financial Overview- Kathy Singh, Controller
  *Strategic and Corporate Opportunities- Matt Vincent, Ph.D., Director of
    Business Development

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc., is a biotechnology company applying cellular
technology in the field of regenerative medicine. For more information,
visitwww.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating
results, future growth in research and development programs, potential
applications of our technology, opportunities for the company and any other
statements about the future expectations, beliefs, goals, plans, or prospects
expressed by management constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Any
statements that are not statements of historical fact (including statements
containing the words “will,” “believes,” “plans,” “anticipates,” “expects,”
“estimates,” and similar expressions) should also be considered to be
forward-looking statements. There are a number of important factors that could
cause actual results or events to differ materially from those indicated by
such forward-looking statements, including: limited operating history, need
for future capital, risks inherent in the development and commercialization of
potential products, protection of our intellectual property, and economic
conditions generally. Additional information on potential factors that could
affect our results and other risks and uncertainties are detailed from time to
time in the company’s periodic reports, including the report on Form 10-K for
the year ended December 31, 2011. Forward-looking statements are based on the
beliefs, opinions, and expectations of the company’s management at the time
they are made, and the company does not assume any obligation to update its
forward-looking statements if those beliefs, opinions, expectations, or other
circumstances should change. Forward-looking statements are based on the
beliefs, opinions, and expectations of the company’s management at the time
they are made, and the company does not assume any obligation to update its
forward-looking statements if those beliefs, opinions, expectations, or other
circumstances should change. There can be no assurance that the Company’s
clinical trials will be successful.

Contact:

Investors:
CEOcast, Inc.
James Young, 212-732-4300
or
Press:
ACT Corporate Communications
Bill Douglass, 646-450-3615
or
Russo Partners
Martina Schwarzkopf, Ph.D., 212-845-4292
or
Business Development:
Advanced Cell Technology
Matthew Vincent, Ph.D., 508-756-1212 x324
mvincent@advancedcell.com
 
Press spacebar to pause and continue. Press esc to stop.